Introduction

Selecting the right manufacturing partner is one of the most critical decisions a pharmaceutical company can make when planning to enter the European market. While product quality and competitive pricing are important, European pharmaceutical companies expect much more from their manufacturing partners.

Regulatory compliance, quality systems, manufacturing capabilities, supply chain reliability, technical expertise, and long-term collaboration all play a decisive role in determining whether a partnership succeeds or fails.

India has emerged as one of the world's largest pharmaceutical manufacturing hubs, supplying medicines to more than 200 countries. Many Indian manufacturers possess EU GMP-certified facilities and have extensive experience supplying regulated markets. However, not every manufacturer is suitable for every product or business model. Choosing a manufacturer solely based on production capacity or commercial quotations can lead to regulatory delays, product quality issues, supply disruptions, or unsuccessful technology transfers.

The selection process should therefore be approached strategically rather than transactionally. Companies must evaluate not only whether a manufacturer can produce a product but also whether they can consistently meet European regulatory expectations throughout the product lifecycle.

This article presents a practical framework that pharmaceutical companies can use when selecting an Indian EU GMP manufacturer for European market entry.

1. Evaluate Regulatory Compliance and Technical Capability

Regulatory compliance should always be the starting point when assessing any pharmaceutical manufacturer. An attractive commercial proposal becomes meaningless if the manufacturer cannot consistently satisfy European regulatory standards.

The first consideration is whether the manufacturing site possesses a valid EU GMP certification issued by a recognized European regulatory authority. Companies should also review the manufacturer's inspection history, observations issued during regulatory inspections, and their experience in handling inspections from agencies such as EMA member states, MHRA, or other international authorities.

However, regulatory approval alone does not guarantee technical suitability. Each dosage form requires specific manufacturing expertise.

For example:

• Sterile injectable products require advanced aseptic manufacturing systems and validated sterile processes.

  Modified-release tablets and capsules demand specialized formulation expertise and process controls.

  Topical creams and gels require sophisticated emulsion technologies and stability management.

  Oral liquid formulations require dedicated manufacturing lines designed to prevent cross-contamination while ensuring microbiological quality.

  The manufacturer's experience with similar products is therefore equally important. Companies should determine whether the manufacturer has previously commercialized comparable formulations for regulated markets and possesses the necessary analytical methods, validation experience, and stability data.

  Another important consideration is dossier support. European market entry involves extensive regulatory documentation, including the Common Technical Document (CTD), validation reports, stability studies, analytical methods, impurity profiles, and product specifications. Manufacturers that routinely support dossier preparation significantly reduce development timelines and regulatory risks.

  Technical capability extends beyond production. A competent manufacturing partner should have experienced formulation scientists, analytical development teams, technology transfer specialists, and regulatory professionals capable of supporting the entire product development process.

  Choosing a manufacturer with strong regulatory and technical capabilities minimizes approval delays while improving the probability of long-term commercial success.

  2. Assess Manufacturing Capacity, Quality Systems, and Business Reliability

  Manufacturing capability is only one aspect of supplier evaluation. Long-term business success depends equally on operational reliability.

  Before selecting a manufacturing partner, companies should evaluate whether the facility has sufficient manufacturing capacity to support both current and future commercial demand. Capacity constraints frequently result in delayed production schedules, inconsistent deliveries, and inventory shortages.